Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis

Castigliano M. Bhamidipati; Jay D. Pal; Thomas K. Jones; James M. McCabe; Mark Reisman; Jason W. Smith; Claudius Mahr; Nahush A. Mokadam

doi:10.1016/j.athoracsur.2016.07.031

Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis

Castigliano M. Bhamidipati, Jay D. Pal, Thomas K. Jones, James M. McCabe, Mark Reisman, Jason W. Smith, Claudius Mahr, Nahush A. Mokadam

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

Original language	English (US)
Pages (from-to)	e101-e104
Journal	Annals of Thoracic Surgery
Volume	103
Issue number	1
DOIs	https://doi.org/10.1016/j.athoracsur.2016.07.031
State	Published - Jan 1 2017
Externally published	Yes

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2016.07.031

Cite this

@article{698d0e2103d244eeb9ac4db5d1e3bebf,

title = "Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis",

abstract = "The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.",

author = "Bhamidipati, {Castigliano M.} and Pal, {Jay D.} and Jones, {Thomas K.} and McCabe, {James M.} and Mark Reisman and Smith, {Jason W.} and Claudius Mahr and Mokadam, {Nahush A.}",

note = "Publisher Copyright: {\textcopyright} 2017 The Society of Thoracic Surgeons",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/j.athoracsur.2016.07.031",

language = "English (US)",

volume = "103",

pages = "e101--e104",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "1",

}

TY - JOUR

T1 - Outflow Graft Obstruction Treated With Transcatheter Management

T2 - A Novel Therapy for a New Diagnosis

AU - Bhamidipati, Castigliano M.

AU - Pal, Jay D.

AU - Jones, Thomas K.

AU - McCabe, James M.

AU - Reisman, Mark

AU - Smith, Jason W.

AU - Mahr, Claudius

AU - Mokadam, Nahush A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

AB - The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

UR - http://www.scopus.com/inward/record.url?scp=85006367215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006367215&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2016.07.031

DO - 10.1016/j.athoracsur.2016.07.031

M3 - Article

C2 - 28007258

AN - SCOPUS:85006367215

SN - 0003-4975

VL - 103

SP - e101-e104

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 1

ER -

Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this